View More Recent Stories
-
Cencora (COR) Tops Q2 EPS by 12c; raises guidance
-
Cencora Inc (COR) PT Raised to $285 at Baird
-
Outlook Therapeutics (OTLK) Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
-
Walgreens Boosts Alliance (WBA) PT Lowered to $11 at Barclays
-
Midday movers: Micron, Levi Strauss, Walgreens and International Paper fall
